AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

Vertex Pharmaceuticals Incorporated ... The company’s pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX ...

"There's crazy things, like, just a cursory examination of Social Security and we've got people in there that are about 150 years old," Musk said. "Now, do you know anyone that's 150? I don't.

Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...

VX-880 (formerly known as STx-02) derives from Vertex’ near $1 billion acquisition of Semma in 2019, and has started enrolling patients in a phase 1/2 study in the US. The therapy takes the form ...

2-Year U.S. Treasury Note Continuous Contract $102.750-0.012-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.500-0.008-0.01% 10-Year U.S. Treasury Note Continuous Contract $109.297-0.016 ...

A claim was initiated with the Standard on 12/4/2024. Two weeks following the required seven-day waiting period, my employee was expecting a STD benefit payment, none arrived. My organization paid ...

Acer Aspire VX-15 is a Windows 10 Home laptop with a 15.60-inch display that has a resolution of 1920x1080 pixels. It is powered by a Core i7 processor and it comes with 8GB of RAM. The Acer Aspire VX ...

What does Nifty Midcap 150 represent? Comprises 150 mid-cap companies listed on the National Stock Exchange (NSE), offering exposure to medium-sized companies with growth potential, providing a ...